IP Verse

Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable Salts - EP2588090

PATENT ANALYSIS

Patent Details

Grant Date
Nov 22, 2023
Company
KRKA TOVARNA ZDRAVIL, D.D., NOVO MESTO
Oppositions

EDER, MICHAEL

GENERICS [UK] LTD

GEORG KALHAMMER/STEPHAN TEIPEL

More patents of Krka Tovarna Zdravil, D.D., Novo Mesto

EP2588090

EP2585051

Want to monitor this patent?

Feel free to send us a message here and we will get back to you